Example: tourism industry

Rufinamide (Inovelon® ) in the treatment of seizures ...

NOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES Date of original recommendation: 22nd June 2010 Date Re-reviewed: 21st October 2014 Rufinamide (Inovelon® ) in the treatment of seizures

Download Rufinamide (Inovelon® ) in the treatment of seizures ...

Please wait..

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam notification

Thank you for your participation!

Submit notification

Broken preview notification

Thank you for your participation!

Submit notification

Other abuse

Documents from same domain

FreeStyle Libre Flash Glucose Monitoring System.

gmmmg.nhs.uk

NOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES November 2017 FreeStyle Libre Flash Glucose Monitoring System. The Formulary and Managed Entry Subgroup discussed the above at its

System, Monitoring, Flash, Glucose, Libre, Freestyle, Freestyle libre flash glucose monitoring system

NTS recommendation Brimonidine gel for acne …

gmmmg.nhs.uk

NOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES 17th June 2014 Brimonidine (Mirvaso® ) gel for the treatment of acne rosacea erythema. The New Therapies Subgroup (NTS) discussed the above drug at a

Brimonidine, Brimonidine gel

Tapentadol (Palexia®) prolonged and immediate …

gmmmg.nhs.uk

November 2015 Tapentadol (Palexia®) prolonged and immediate release tablets for the treatment of acute and chronic severe pain. The New Therapies Subgroup of the Greater Manchester Medicines

Release, Tablets, Immediate, Prolonged, Tapentadol, Prolonged and immediate release tablets

Hydrocortisone modified release tablet …

gmmmg.nhs.uk

NOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES 17th April 2014 Hydrocortisone modified release tablet (Plenadren®) for the treatment of adrenal …

Adrenal

Low Strength Antipsychotic Prescribing in Dementia: A GP ...

gmmmg.nhs.uk

GMMMG – championing the appropriate use of medicines across Greater Manchester PAGE | 4 AIM AIM To aid the primary care review of low strength antipsychotic prescribing in dementia patients.

Prescribing, Antipsychotic, Dementia, Strength, Low strength antipsychotic prescribing in dementia

Chapter 4. Central Nervous System - GMMMG

gmmmg.nhs.uk

Greater Manchester Joint Formulary Return to contents page V6.6 Page 6 of 32

System, Chapter, Central, Chapter 4, Nervous, Central nervous system

GMMMG COPD Formulary Inhaler Options September 2018 ...

gmmmg.nhs.uk

GMMMG COPD Formulary Inhaler Options – September 2018 Produced by Regional Drug and Therapeutics Centre (RDTC) for the GMMMG. September 2018 BNF 3.1.2 – Antimuscarinic bronchodilators (LAMA) 1st choice Alternatives Tiotropium Aclidinium Glycopyrronium Umeclidinium

Non-pharmacological management for ALL patients

gmmmg.nhs.uk

6 Treatment of new COPD patients FEV 1 Spirometry (measuring FEV 1 and FVC) is needed to make the diagnosis of COPD. FEV 1 can be used to measure worsening or improvement in patients.

Copd

Cost Comparison Charts - GMMMG

gmmmg.nhs.uk

Regional Drug and Therapeutics Centre Cost comparison charts 2 Jul 2019

Chart, Comparison, Cost, Cost comparison charts

Management of Vitamin D Deficiency, Insufficiency and ...

gmmmg.nhs.uk

Patient group Advice ... (for example, they have osteomalacia).2 Routine screening of high risk groups is not indicated. For convenience, paediatric reference ranges and definitions of deficiency used here are the same as for adults as per the NOS guidance.3 Any child who is suspected to be hypocalcaemic secondary

Patients, Secondary, Osteomalacia